These final results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the thought of concentrating on ACKR3 as a novel way to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Issues. We independently study, https://napoleona272mrt3.targetblogs.com/profile